Exact Sciences: Q4 Earnings Snapshot

SelfRugger · 2026-02-13T21:44:05+00:00

Exact Sciences Corp. reported an $86 million loss in Q4, with a per-share loss of 45 cents, exceeding revenue expectations at $878.4 million. For the year, the company reported a total loss of $207.9 million on $3.25 billion revenue.

SelfRugger

2026-02-13 21:44:05

Abstract generation in progress

Exact Sciences: Q4 Earnings Snapshot

Associated Press Finance

Sat, February 14, 2026 at 6:21 AM GMT+9 1 min read

In this article:

EXAS

+0.01%

MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Friday reported a loss of $86 million in its fourth quarter.

On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 45 cents. Losses, adjusted for amortization costs and non-recurring costs, came to 21 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.

The molecular diagnostics company posted revenue of $878.4 million in the period, which beat Street forecasts. Six analysts surveyed by Zacks expected $860.6 million.

For the year, the company reported a loss of $207.9 million, or $1.10 per share. Revenue was reported as $3.25 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.